Mixed Results From Retinopathy Prevention Trial

(MedPage Today) -- Prophylactic anti-VEGF therapy with aflibercept (Eylea) slowed the progression of diabetic eye disease but did not preserve visual acuity any better than deferred treatment, a randomized trial showed.
After 2 years of follow...